Incremental cost-effectiveness of BV + AVD compared with ABVD over a range of potential clinical benefit. *Assumes 2-year modified PFS with ABVD of 76.9%. The displayed absolute percentage differences correspond to hazard ratios of 0.4, 0.5, 0.6, 0.7, 0.8, and 0.9.